Novartis transforms its Global Health & Corporate Responsibility organization.
For over 40 years Novartis has been committed to understanding sickle cell disease and working towards treatment.
Novartis reaffirms commitment to fighting malaria and recognizes the dedication of our people and partners.
Novartis announced the company’s financial results for the first quarter of 2019.
On April 9, 2019 Alcon becomes a separately traded company. Novartis and Alcon are now positioned to capitalize on significant growth opportunities and focus resources on their respective businesses and strategic priorities.
The first pan-African Novartis Social Business stakeholder dialogue took place in Kampala, Uganda, on March 20, 2019.
Fourteen weeks. That’s how many weeks all new Novartis parents will get as minimum paid parental leave, regardless of gender, rolling out from July 1, 2019.
Novartis CEO Vas Narasimhan announced the company’s fourth quarter and 2018 full year results.
More than 100 people from 15 Asian countries participated in the fourth Novartis Social Business stakeholder dialogue in Singapore on November 20.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.